|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 67,15 USD | -8,21% |
|
-19,18% | -1,10% |
| 07/08 | HALOZYME THERAPEUTICS, INC. : Morgan Stanley toujours à l'achat | ZM |
| 06/08 | Transcript : Halozyme Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,16% | -1,24% | -0,22% | +14,50% | +22,15% | +59,99% | +21,20% | +70,44% | +101,35% | 317 Md | |
| -1,03% | +0,35% | +1,34% | +25,19% | +17,17% | +37,33% | -10,25% | -20,28% | +45,25% | 72,72 Md | |
| +20,24% | +24,93% | +26,42% | +58,18% | +53,22% | +66,05% | +145,47% | +154,62% | +883,03% | 10,17 Md | |
| +1,29% | -3,91% | -6,91% | +6,37% | +0,77% | -2,66% | -2,71% | -26,40% | +53,03% | 8,31 Md | |
| +2,28% | +10,05% | +1,67% | -13,30% | -31,46% | -15,86% | -11,32% | -32,76% | - | 4,6 Md | |
| +3,60% | +8,92% | +15,80% | -8,20% | -28,29% | -29,61% | +15,14% | +50,49% | +96,18% | 4,08 Md | |
| +14,37% | +25,87% | +2,23% | +32,60% | +50,37% | +1,49% | +42,79% | -18,34% | - | 3,83 Md | |
| +1,88% | +6,74% | -0,63% | -8,88% | -4,14% | +14,91% | +47,72% | +80,45% | +106,14% | 2,72 Md | |
| +4,26% | +1,16% | +0,85% | -11,37% | -12,10% | -1,05% | -2,51% | +80,17% | - | 2,16 Md | |
| +9,74% | +14,61% | +3,19% | -7,64% | +1,78% | -18,30% | +40,81% | -24,94% | - | 1,78 Md | |
| +1,40% | -1,58% | -3,23% | -9,66% | -13,86% | -22,80% | -16,43% | -8,23% | -42,00% | 1,7 Md | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1,64 Md | |
| -3,42% | -3,92% | +18,18% | +43,78% | +163,75% | +192,27% | +1 570,41% | +659,80% | - | 1,26 Md | |
| -1,80% | +6,86% | -8,71% | -37,21% | -39,51% | +43,61% | +35,74% | +20,22% | +453,30% | 1,19 Md | |
| +4,96% | +14,33% | -15,07% | -28,32% | -13,06% | -45,31% | -15,69% | - | - | 1,18 Md | |
| +11,27% | +23,37% | -23,17% | -4,54% | +17,56% | +5,57% | +95,94% | +10,81% | - | 1,06 Md | |
| +3,49% | -1,43% | +0,73% | -3,94% | -10,75% | -7,78% | +21,88% | +80,43% | +69,73% | 1,05 Md | |
| -1,13% | +23,06% | +4,64% | -29,68% | -22,68% | +10,78% | +8,37% | +2,34% | +186,48% | 951 M | |
| +4,77% | +6,55% | +4,14% | -14,04% | -17,23% | -33,83% | -72,63% | -80,98% | - | 913 M | |
| Moyenne | +4,02% | +5,30% | +1,18% | +0,21% | +7,43% | +14,16% | +106,33% | +58,70% | +195,25% | 23,07 Md | |
| Moyenne pondérée par Capi. | +0,74% | +0,16% | +0,69% | +15,92% | +20,17% | +51,25% | +22,56% | +53,76% | +110,12% |
- Bourse
- Actions
- Action HALO
- Action 0J2O
- Secteur Halozyme Therapeutics, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
